CXC chemokines in angiogenesis

Journal of Leukocyte Biology

Volumn 68, Issue 1, 2000, Pages 1-8

  Belperio, J A ^a   Keane, M P ^a   Arenberg, D A ^a   Addison, C L ^a   Ehlert, J E ^a   Burdick, M D ^a   Strieter, R M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cytokines; Neovascularization; Tumor metastasis; Tumorigenesis; Wound repair

Indexed keywords

ALPHA CHEMOKINE; INTERFERON;

AMINO ACID COMPOSITION; AMINO TERMINAL SEQUENCE; ANGIOGENESIS; GENE INDUCTION; GENE STRUCTURE; GENETIC CONSERVATION; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW;

AMINO ACID MOTIFS; ANGIOGENESIS INHIBITORS; ANIMALS; ARTHRITIS, RHEUMATOID; CHEMOKINES, CXC; CHRONIC DISEASE; FIBROSIS; HUMANS; INFLAMMATION; INTERLEUKIN-8; MICE; MICE, NUDE; NEOPLASM PROTEINS; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; NEOVASCULARIZATION, PHYSIOLOGIC; PULMONARY FIBROSIS; RECEPTORS, CHEMOKINE; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0033848994     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (102)

1. Angiogenesis induction by tumors, embryonic tissues, and lymphocytes
2. Angiogenesis in cancer, vascular, rheumatoid and other disease
3. Tumor angiogenesis
4. The role of angiogenesis in tumor growth
5. Angiogenesis
6. Angiogenesis and inflammation
7. Macrophages, wound repair and angiogenesis
8. The pathophysiology of angiogenesis
9. How the extracellular matrix and macrophages contribute to angiogenesis-dependent diseases
10. Activated macrophages induce vascular proliferation
11. Cell turnover of capillaries
12. The proliferation of capillary and endothelial cells
13. Angiogenesis: A mechanism by which oncogenes and tumor suppressor genes regulate tumorigenesis
14. Chemokines - Chemotactic cytokines that mediate inflammation
15. Chemokines
16. Chemokines and leukocyte traffic
17. Human chemokines: An update
18. Interleukin-8 and related chemotactic cytokines
19. Chemokines: Leucocyte recruitment and activation cytokines
20. CXC chemokines in regulation of angiogenesis
21. The role of CXC chemokines as regulators of angiogenesis
22. The functional role of the ELR motif in CXC chemokine-mediated angiogenesis
23. Chemokines and the lung
24. Chemokines, inflammation and the immune system
25. CXC chemokines - An overview
26. The molecular and cellular biology of the chemokines
27. Human interferon-inducible protein 10 is a potent inhibitor of angiogenesis in vivo
28. The IP-10 chemokine binds to a specific cell surface heparan sulfate site shared with platelet factor 4 and inhibits endothelial cell proliferation
29. Mig, the monokine induced by interferon-gamma, promotes tumor necrosis in vivo
30. Interleukin-8 stimulates angiogenesis in rats
31. Interleukin-8 as a macrophage-derived mediator of angiogenesis
32. Interleukin-8. A corneal factor that induces neovascularization
33. Interleukin-8 and de novo mammalian angiogenesis
34. Involvement of interleukin-8, vascular endothelial growth factor, and basic fibroblast growth factor in tumor necrosis factor alpha-dependent angiogenesis
35. Point mutation causing constitutive signaling of CXCR2 leads to transforming activity similar to Kaposi's sarcoma herpesvirus-G protein-coupled receptor
36. Transcription mapping of the Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) genome in a body cavity-based lymphoma cell line (BC-1)
37. Transformation of primary human endothelial cells by Kaposi's sarcoma-associated herpesvirus
38. Inhibition of constitutive signaling of Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor by protein kinases in mammalian cells in culture
39. G-protein-coupled receptor of Kaposi's sarcoma-associated herpesvirus is a viral oncogene and angiogenesis activator
40. Agonists and inverse agonists for the herpesvirus 8-encoded constitutively active seven-transmembrane oncogene product, ORF-74
41. Chemokines activate Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor in mammalian cells in culture
42. HuMIG: A new member of the chemokine family of cytokines
43. Mig and IP-10: CXC chemokines that target lymphocytes
44. A macrophage mRNA selectively induced by gamma-interferon encodes a member of the platelet factor 4 family of cytokines
45. A collection of mRNA species that are inducible in the RAW 264.7 mouse macrophage cell line by gamma interferon and other agents
46. Gamma-interferon transcriptionally regulates an early-response gene containing homology to platelet proteins
47. Biochemical characterization of a gamma interferon-inducible cytokine (IP-10)
48. Chemokine receptors in human endothelial cells. Functional expression of CXCR4 and its transcriptional regulation by inflammatory cytokines
49. Vascular endothelial growth factor and basic fibroblast growth factor induce expression of CXCR4 on human endothelial cells: In vivo neovascularization induced by stromal-derived factor-1 alpha
50. Defects of B-cell lymphopoiesis and bone-marrow myelopoiesis in mice lacking the CXC chemokine PBSF/SDF-1
51. The chemokine receptor CXCR4 is essential for vascularization of the gastrointestinal tract
52. Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar development
53. In vitro and in vivo systems to assess role of C-X-C chemokines in regulation of angiogenesis
54. Interferon-inducible T cell alpha chemoattractant (I-TAC): A novel non-ELR CXC chemokine with potent activity on activated T cells through selective high affinity binding to CXCR3
55. Interleukin-12 and interleukin-18 synergistically induce murine tumor regression which involves inhibition of angiogenesis
56. Chemokine receptor specific for IP10 and mig: Structure, function, and expression in activated T-lymphocytes
57. The CC chemokine 6Ckine binds the CXC chemokine receptor CXCR3
58. Inhibition of angiogenesis by recombinant human platelet factor-4 and related peptides
59. Inhibition of endothelial cell proliferation by platelet factor-4 involves a unique action on S phase progression
60. Selective binding of platelet factor 4 to regions of active angiogenesis in vivo
61. Recombinant platelet factor 4, an angiogenic marker for human breast carcinoma
62. Platelet factor 4 blocks the binding of basic fibroblast growth factor to the receptor and inhibits the spontaneous migration of vascular endothelial cells
63. 165 using several concurrent mechanisms
64. Platelet factor 4 modulates fibroblast growth factor 2 (FGF-2) activity and inhibits FGF-2 dimerization
65. Inhibition of in vitro angiogenesis by platelet factor-4-derived peptides and mechanism of action
66. Dual regulation of vascular endothelial growth factor bioavailability by genetic and proteolytic mechanisms
67. The vascular endothelial growth factor family: Identification of a fourth molecular species and characterization of alternative splicing of RNA
68. Inhibition of human umbilical vein endothelial cell proliferation by the CXC chemokine, platelet factor 4 (PF4), is associated with impaired downregulation of p21(Cip1/WAF1)
69. Gro-beta, a -C-X-C- chemokine, is an angiogenesis inhibitor that suppresses the growth of Lewis lung carcinoma in mice
70. Mechanism and biological significance of constitutive expression of MGSA/GRO chemokines in malignant melanoma tumor progression
71. Enhanced tumor-forming capacity for immortalized melanocytes expressing melanoma growth stimulatory activity/growth-regulated cytokine beta and gamma proteins
72. Expression of angiogenesis-related genes and progression of human ovarian carcinomas in nude mice
73. Angiogenic activity and interleukin-8 content of human ovarian cancer ascites
74. Inhibition of IL-8 attenuates angiogenesis in bronchogenic carcinoma
75. Inhibition of interleukin-8 reduces tumorigenesis of human non-small cell lung cancer in SCID mice
76. Interleukin-8 participates in angiogenesis in non-small cell, but not small cell carcinoma of the lung
77. Epithelial-neutrophil activating peptide (ENA-78) is an important angiogenic factor in non-small cell lung cancer
78. Endostatin: An endogenous inhibitor of angiogenesis and tumor growth
79. Angiostatin induces and sustains dormancy of human primary tumors in mice
80. Microvessel density in prostate cancer: Prognostic and therapeutic utility
81. Tumor-associated angiogenesis in prostate cancer
82. Interleukin-8 serum levels in patients with benign prostatic hyperplasia and prostate cancer
83. Distinct CXC chemokines mediate tumorigenicity of prostate cancer cells
84. Expression of interleukin-8 correlates with vascularity in human gastric carcinomas
85. Expression of interleukin 8 correlates with the metastatic potential of human melanoma cells in nude mice
86. Burkitt's lymphoma cell lines reveal different degrees of tumorigenicity in nude mice
87. Interferon-inducible protein-10 identified as a mediator of tumor necrosis in vivo
88. The role of Mig, the monokine induced by interferon-gamma, and IP-10, the interferon-gamma-inducible protein-10, in tissue necrosis and vascular damage associated with Epstein-Barr virus-positive lymphoproliferative disease
89. Interferon-gamma-inducible protein 10 (IP-10) is an angiostatic factor that inhibits human non-small cell lung cancer (NSCLC) tumorigenesis and spontaneous metastases
90. Neoplasms of the lung
91. Cancers of the lungs
92. Tumor angiogenesis correlates with histologic type and metastasis in non-small cell lung cancer
93. Stimulation of neovascularization by human rheumatoid synovial tissue macrophages
94. Aberrant production of interleukin-8 and thrombospondin-1 by psoriatic keratinocytes mediates angiogenesis
95. Precapillary systemic-pulmonary anastomoses
96. Neoformation of blood vessels in association with rat lung fibrosis induced by bleomycin
97. The CXC chemokines, IL-8 and IP-10, regulate angiogenic activity in idiopathic pulmonary fibrosis
98. IFN-gamma-inducible protein-10 attenuates bleomycin-induced pulmonary fibrosis via inhibition of angiogenesis
99. Neutralization of the CXC chemokine, macrophage inflammatory protein-2, attenuates bleomycin-induced pulmonary fibrosis
100. A preliminary study of long-term treatment with interferon gamma-1b and low-dose prednisolone in patients with idiopathic pulmonary fibrosis
101. Interferon gamma-1b for the treatment of idiopathic pulmonary fibrosis